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a  b  s  t  r  a  c  t
Unlike  what  is  widely  anticipated  by the  public,  herbal  medicines  are not  always  safe  despite  being
natural.  We  describe  a 65-year-old  Chinese  man  taking  a prolonged  maintenance  dose  of warfarin  who
experienced  an  elevated  international  normalized  ratio (INR) with  associated  bleeding  after  drinking
Gouqizi  (goji  berry)  wine.  This  report  illustrates  that large  doses  (more  than 6–12 g) of  Gouqizi  can  sig-
niﬁcantly  enhance  the anticoagulant  action  of warfarin  and  may  cause  similar  adverse  effects  in  keepingeywords:
arfarin
ouqizi
ycium barbarum L.
rug–herb interactions
CM
with three  previous  reports.  Therefore,  the  use  of herbal  medicines  must  adhere  to  pharmacopoeia-
recommended  guidelines,  including  dosage  regimes.  Doctors  should  advise  patients  regarding  possible
interactions  between  herbs  and  warfarin  when  prescribing  and  should  increase  the  frequency  of INR  mon-
itoring for  those  patients  concurrently  receiving  warfarin  and medicinal  herbs.  Further  study  is  needed
to  do for  the  mechanism  of  interaction  between  Gouqizi  and warfarin.
© 2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CCWarfarin is the most commonly used oral anticoagulant pre-
cribed for patients with prosthetic heart valves, atrial ﬁbrillation,
ulmonary embolism and venous thrombosis [5]. The use of war-
arin introduces challenges not only because it is known to have
 narrow therapeutic range and risk of bleeding, but also because
here are patient variables and potential drug–drug, drug–food and
rug–herb interactions that can complicate its management [16].
he dosage of warfarin must be adjusted according to the inter-
ational normalized ratio (INR) and patients are treated to obtain
ertain target INR ranges [5]. If the INR is lower than the target
NR, there is the risk of thrombosis; however, if the INR is higher
han the target INR, there is a high risk of bleeding. Consequently,
n hospital patients are closely monitored and the risk of bleeding
nd thrombosis are considered, allowing the dose of warfarin to
e adjusted as necessary. However, when patients are discharged
rom hospital, there is an increased risk that they may  take other
edicines and/or herbs, possibly prescribed by another doctor, and
hat their diet may  change, resulting in an increased risk of bleed-
ng or thrombosis due to interactions between warfarin and herbs
r foodstuffs.
In China, traditional Chinese medicine (TCM) is popular for the
reatment of minor ailments, such as colds or fevers, and herbs
∗ Corresponding author. Fax: +86 591 83357896.
E-mail address: pollyzhang2006@126.com (J. Zhang).
ttp://dx.doi.org/10.1016/j.toxrep.2015.08.011
214-7500/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
are often prescribed to patients by TCM practitioners. In the case
of more serious conditions, patients generally combine TCM with
Western medicine. In addition, culinary herbs are typically con-
sumed seasonally in order to maintain good health. Taking into
account all of the above, it may  be considered that there is an
increased risk of drug–herb interactions in patients consuming culi-
nary herbs for medicinal purposes or those taking TCMs, which may
lead to the enhanced or reduced effect of warfarin, possibly leading
to bleeding or thrombosis.
TCMs, such as Danshen [3], Ginkgo biloba and Dong quai [4] have
been reported to enhance the anticoagulation activity of warfarin,
while Panax ginseng [4] has been reported to impede its action.
Lycium barbarum L., also known as goji berry and widely used in
food (6–12 g daily) and herbal medicine(6–12 g daily), is deﬁned in
the Chinese Pharmacopoeia as Gouqizi. It belongs to the Solanaceae
family and, typically, the dried ripe fruit of Lycium barbarum L.
(Ningxia gouqi) are harvested from summer to autumn (Chinese
Pharmacopoeia, Fig. 1). Polysaccharides represent quantitatively
the most important group of substances in Lycium barbarum L. [12].
Gouqizi is used in TCM as a mild Yin tonic, enriching Yin in
the liver and kidneys whilst moistening lung Yin. Clinical man-
ifestations derived from Yin deﬁciencies include blurred vision
and diminished visual perception, infertility, abdominal pain, dry
cough, fatigue and headaches [12]. Gouqizi is also a popular ingre-
dient in Chinese herbal cuisine and is consumed in soups and
porridge, as well as with seafood, meat and vegetables. For its health
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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Cig. 1. Lycium barbarum L., also known as goji berry and widely used in food and
erbal medicine, is deﬁned in the Chinese Pharmacopoeia as Gouqizi.
eneﬁts, Gouqizi is traditionally consumed in the form of tea, juice
r wine in China.
To date, three articles focused on the interaction between
ouqizi and warfarin have been published: two case reports from
merica [13,8] and one case from Hong Kong [9]. In these three
ases, Gouqizi was ingested as a form of juice or tea. In both cases,
atient’s INR increased after consuming the juice or tea. In this case
eport, we provide additional evidence for the interaction between
arfarin and Gouqizi contained in a wine product commonly sold
n China.
. Case report
A 65-year-old Chinese man  with a history of prosthetic heart
alve replacement had been stabilized on warfarin anticoagulation
herapy for two years. He has no other medical conditions and his
nly medication was warfarin. The patient was compliant regarding
he attendance of appointments and in taking the medication, and
aintained a therapeutic INR (1.7–2.5) on a maintenance daily dose
f 1.875 mg  warfarin with monthly INR monitoring. The patient did
ot exhibit symptoms of ecchymosis, nosebleeds, bleeding gums or
lood clots and denied drinking and smoking.
On the morning of November 10, 2013, the patient developed
acroscopic hematuria and consequently attended hospital. The
rine test results conﬁrmed hematuria with an abnormal urinary
ed blood cell count of 33201.5/l (the normal range is 0–23/l)
nd an INR of 3.84. The patient did not report any change in the
able 1
ase reports describing interactions between warfarin and Gouqizi.
Case Location Indication Gouqizi
form
Lam and Elmer [8] Seattle, WA,  USA AFa Tea 
Leung  et al. [9] Hong Kong, China AFa Tea
Rivera  et al. [13] Los Angeles, CA, USA Knee surgery Juice 
Current case Fujian, China PHVb, AFa Wine 
a AF: atrial ﬁbrillation.
b PHV: prosthetic heart valve.
c Gouqizi: Lycium barbarum L. (also known as goji berry or Chinese wolfberry).rts 2 (2015) 1209–1212
state of his condition and denied taking any additional medication
or a change in diet or lifestyle; however, he indicated that he had
consumed 20 ml  of Gouqizi wine in the evening on November 9
on the advice of a friend as he was  suffering from blurred vision.
Although the patient was  aware that the wine could inﬂuence the
therapeutic effect of warfarin, he had previously consumed 60 ml
of wine (not containing Gouqizi) and not experienced any negative
effects.
Application of the Naranjo Adverse Drug Reaction (ADR) Scale
[11] indicated a probable relationship (score of 6) between the ele-
vated INR with hematuria and the patient’s concomitant use of
warfarin and Gouqizi. The patient was advised to discontinue the
use of Gouqizi wine and to abstain from warfarin for 2 days. On the
morning of November 11, the patient continued to see blood in the
urine, with diminished color intensity; by the evening, the hema-
turia had resolved. On November 12, the patient’s INR was  2.12 and
urine test results were normal with a urinary red blood cell count
of 11/l. He continued warfarin at a daily dose of 1.875 mg  and the
INR was  found to be 2.0 after 1 week (Table 2).
2. Discussion
Gouqizi is a highly nutritional fruit, which has been used for
more than 2000 years in China for the prevention and treatment of
disease as part of TCM with early records dating back to the Tang
Dynasty (1000–1400 AD) [2]. TCM uses both the fruit and root bark
of Lycium barbarum L., where the fruit (Gouqizi) is used to tonify
Yin, while the root bark (Digupi) is used to “clean” the heart. Nowa-
days, Gouqizi is widely used for its anti-aging properties and as a
health food worldwide. It is thought to play an important role in
preventing and treating various chronic diseases, such as diabetes,
hyperlipidemia, thrombosis, immunodeﬁciency, cancer, hepatitis
and male infertility [6]. Previously, Amagase et al. [1] showed that
Gouqizi has a high nutrient value and contains high levels of antiox-
idants, with 68% carbohydrate, 12% protein, 10% ﬁber and 10% fat.
In this case report, the Naranjo ADR score of 6 showed that
the patient’s elevated INR and related bleeding may be due to
an interaction between warfarin and Gouqizi wine. Karlson et al.
[7] previously showed that administration of 375 ml  wine did
not result in thrombin times (TTs) outside the therapeutic range,
which suggested that a moderate intake of alcohol occasionally
may  be acceptable during anticoagulant therapy. In this case, the
patient had previously consumed 60 ml  of wine without a negative
effect, suggesting that the reported hematuria was not due to the
Gouqizi
dose
INR before
Gouqizi
INR after
Gouqizic
Treatment
72∼96 oz 2.5 4.1 Warfarin
withheld for 1
day
50 g 3.0 4.97 Warfarin
withheld for 2
days
40  g 2.75 3.86 Warfarin
withheld for 2
days
240 ml No INR
measured
PT: 120 s with
epistaxis,
bruising and
rectal bleeding
Phytonadione,
15 mg
20 ml  2.46 3.84 with
hematuria
Warfarin
withheld for 2
days
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Table  2
INR vs warfarin dose (mg) before and after consumption of Gouqizi wine.
16-Jul-2013 19-Aug-2013 17-Sept-2013 16-Oct-2013 10-Nov-2013 11-Nov-2013 12-Nov-2013 19-Nov-2013
INR 2.11 2.1 1.91 2.46 3.84 – 2.12 2.0
Warfarin (mg) 1.875 1.875 1.875 1.875 – – 1.875 1.875
Fig. 2. INR vs warfarin dose (mg) for three patients before and during treatment with Gouqizi (6 g/day) for 3 days. A starting INR was taken before taking Gouqizi on 15
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onsecutive days (15–17 January 2015), then the INR was taken in the fourth day (1
 is 2.41).
lcohol content of the herbal wine. Furthermore, we  eliminated the
nﬂuence of another disease (such as fever, diarrhea, thyroid hyper-
unction, etc.), other drugs (antibiotics, statins, amiodarone, etc.) or
ther herbs (Danshen, Ginkgo biloba,  Dong quai, etc.). The patient
id not report any changes to his lifestyle or diet. As such, we con-
idered that Gouqizi may  have enhanced the effect of warfarin, thus
eading to the occurrence of hematuria.
In China, Gouqizi is a popular component of the daily diet, mak-
ng the prohibition of its consumption in patients taking warfarin
ifﬁcult to implement. It should be noted that the previous pub-
ished cases reporting adverse interactions between Gouqizi and
arfarin in Table 1 indicated that the dosages of Gouqizi taken by
he patients were larger (case 1 is 72–96 OZ; case 2 is 50 g and
0 g; case 3 is 240 ml;  case 4 is 20 ml)  than that recommended by
he Chinese Pharmacopoeia (6–12 g) (Pharmacopoeia of The Peo-
le’s Republic of China, 2010). Furthermore, symptoms induced by
he interaction between Gouqizi and warfarin can be managed by
ithholding warfarin or the use of vitamin K (Table 1). However,
t is important to establish the dosage of Gouqizi that can enhance
he effect of warfarin. The little study in Appendix A showed that
 g of Gouqizi daily is a safe dose for patients taking warfarin.
In China it is common to use Western medicine alongside TCM
o treat disease and this may  explain the increased risk of warfarin-
nduced bleeding in China compared to other countries [10]. Due to
ublic concern regarding the risk of bleeding during treatment with
arfarin, as well as the uneasy relationship between allopathic doc-
ors and their patients, no more than 10% of patients with atrial
brillation take warfarin in China [5]. Thus, we  encourage the col-
ection and publication of data focused on the interactions between
CMs and warfarin, as well as the consequential risk of bleeding or
hrombosis, to promote the use of warfarin in Chinese patients and
o better prevent thrombi. Such data may  also alert doctors from all
ountries to the risk of warfarin-induced bleeding due to the effects
f TCMs.
. Conclusion
This case revealed that Gouqizi can enhance the anticoagulant
ffect of warfarin and may  consequently cause bleeding. However,
 daily Gouqizi dose of 6 g (dosing recommended by Chinese Phar-
acopoeia) for 3 days did not enhance the effects of warfarin in
hree patients with prosthetic heart values who  were concomi-
antly taking warfarin. Further study is needed to establish the dose
f Gouqizi that can have an additive effect on the anticoagulantt 3 is 2.33), and then Gouqizi (6 g) tea was administered in the evening for three
ary 2015, he INR of patient 1 is 2.23, the INR of patient 2 is 2.37, the INR of patient
activity of warfarin. Pharmacists and doctors who manage anti-
coagulation clinics should pay particular attention to patients who
take warfarin concomitantly with TCMs and INR monitoring should
be increased in such patients. Furthermore, patients should be bet-
ter educated with regards to the possible interactions between
warfarin and herbal medicines.
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Appendix A.
The interaction study of warfarin and Lycium barbarum L.
Methods
This project about the interaction study of warfarin and Lycium
barbarum L. is approved by Fujian Medical University Union Hospi-
tal ethics committee (NO: 2015KY002). This study required patients
who had taken warfarin for at least three monthes. Three patients
with prosthetic heart valves were included in this study. The tea
was made by boiling 6 g of Gouqizi in 3 cups of water and the vol-
ume  was then concentrated to around 1 cups by simmering [9]. A
starting INR was taken before taking Gouqizi, and then Gouqizi (6 g)
was administered as a tea for three consecutive days, then the INR
was taken in the fourth day.
Results and discussion
The results showed that, during the 3-day study period when
the patients concurrently took warfarin (no other medication), a
daily dose of 6 g (dosing recommended by Chinese Pharmacopoeia
is 6–12 g daily) Gouqizi (total dose: 18 g) did not affect the INR,
which remained within the target range (1.7–2.5) for all three
patients (Fig. 2), suggesting that this may  represent a safe dose.
In these four cases in Table 1, the dosing of Gouqizi is larger (case
1 is 72–96 OZ; case 2 is 50 g and 40 g; case 3 is 240 ml;  case 4 is
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0 ml). So maybe it is safe for patients who take warfarin concomi-
antly with Gouqizi 6 g daily, and it is unsafe for patients who  take
arfarin concomitantly with Gouqizi more than 6 g daily. How-
ver, the limitations of this small study should be considered in the
nterpretation of these results as it was not convenient to collect the
atients’ blood samples for further determination of drug concen-
rations in the blood because the patients lived in various regions
f the Fujian province. Thus, further research is needed to establish
 safe dose of Gouqizi to use alongside warfarin treatment and to
tudy the possible mechanism of interaction between Gouqizi and
arfarin.
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